WADDILL WILLIAM D. sold 71.9% of their position (20K shares) of PROTAGONIST THERAPEUTICS, INC on the open market
Open‑market sale worth $1.67M — a major position exit. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 2/6/2026ACC: 0001104659-26-011575
Director
Since Jun 2019
-20K
Net shares
Net seller
$1.67M
Total sold
1
Open market trades
0B · 1S
3
Total transactions
20K acquired · 40K disposed
Non-Derivative Transactions2
Common Stock
Direct
Shares
+20K
Price / share
$8.31
Trade value
$166.20K
% of position
255.6%
2/6/2026
7.83K→27.82K
Common Stock
Direct
Shares
−20K
Price / share
$83.68
Trade value
$1.67M
% of position
71.9%
2/6/2026
27.82K→7.83K
Total
Net shares
+0.00
Net value
-$1.51M
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 2/6/2026 | M · Option Exercise | +20K | $8.31 | $166.20K | 255.6% | 7.83K | 27.82K |
| Common Stock Direct | 2/6/2026 | S · Sale | −20K | $83.68 | $1.67M | 71.9% | 27.82K | 7.83K |
| Total | +0.00 | -$1.51M | ||||||
Derivative Transactions1
Stock Option (right to buy)
Direct
Converts to
Common Stock
20K shares
Shares
−20K
Strike price
8.31
Held after
0.00
Exercisable
—
2/6/2026
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Stock Option (right to buy) Direct | Common Stock20K shares | 2/6/2026 | M · Option Exercise | −20K | 8.31 | — | 0.00 |